4/A: Intelligent Bio Solutions CFO Sakiris Receives Stock Grant, Corrects Previous Reporting Errors

Spiro Kevin Sakiris, CFO of Intelligent Bio Solutions Inc., received 34,500 shares of common stock and corrected previous reporting errors regarding his holdings.

Summary

• On September 25, 2024, Intelligent Bio Solutions Inc. granted Spiro Kevin Sakiris, the Chief Financial Officer, 34,500 shares of common stock under the 2019 Long Term Incentive Plan.
• An amendment was filed on March 31, 2025, to correct clerical errors in previous filings.
• The number of directly held securities was adjusted to correct an underreporting error of 1 share.
• The number of indirectly held securities was adjusted to correct an overreporting error of 65 shares.
• Sakiris also indirectly owns 19,115 shares held by Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, where he serves as a director.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock grant to the CFO is a positive sign, and the correction of errors indicates diligence. However, it's a routine filing.

Positives

• The grant of 34,500 shares to the CFO aligns his interests with the company's long-term performance.
• The correction of reporting errors demonstrates a commitment to accurate financial disclosures.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Stakeholder Impact

• Shareholders benefit from transparent reporting of insider transactions.
• The stock grant incentivizes the CFO to work towards the company's success.

Key Dates

Keywords

Form 4, Beneficial Ownership, Spiro Sakiris, Intelligent Bio Solutions, INBS, Stock Grant, CFO, Amendment